Search

Aim: The aim of this study was to investigate the sociodemographic and clinical characteristics of the patients using continuous subcutaneous insulin infusion (CSII) therapy. We reported the effects of CSII therapy on some clinical parameters. Materials and methods: One hundred twenty-seven patients using CSII therapy were enrolled in the study. A total of 102 patients were included after 25 cases were excluded due to inadequate data. Sociodemographic, clinical, and laboratory characteristics were obtained from the hospital database. Results: In our study, no relationship was found between educational level and the effective use of carbohydrate counting and diabetes complications. After switching to CSII therapy, patients' glycated hemoglobin (HbA1c) levels were reduced to 8.2% (5.3–14) at their last visit (p = 0.005). Also, total daily insulin dosage with 48 IU/day (7.3–180) was significantly decreased to 40 IU/day (15–276) after CSII therapy (p = 0.001). CSII therapy was significantly associated with less episodes of diabetic ketoacidosis at the last visit than at the initiation of CSII therapy (p = 0.033). Conclusion: Switching to CSII therapy can improve glycemic control, reduce insulin dosage requirements, and improve patient quality of life by reducing episodes of diabetic ketoacidosis. [ABSTRACT FROM AUTHOR]

Background: Global COVID-19 outbreak has been such a stressful experience for most of the people. Using a web-based cross-sectional study, we aimed to evaluate the acute stress response, depression, and anxiety in patients with diabetes mellitus (DM) during the COVID-19 pandemic, and to examine the effect of these psychiatric problems on diet habits and glycemic controls of patients. Methods: This web-based survey of COVID-19 was sent to the patients through the Whatsapp platform. All participants reported their demographic data, diabetes-related information, changes in self-monitoring blood glucose measurements, physical parameters, and eating habits after COVID-19, then completed Hospital Anxiety and Depression Scale (HADS) and the Impact of Event Scale, Revised (IES-R) questionnaires which assessed acute stress sypmtoms, anxiety, and depression. Results: Three hundred and four patients with DM [(141 type 1 DM (T1D) and 163 type 2 (T2D)] were included in the study. In our study, female gender, higher BMI and weight, decreased in financial income after outbreak, presence of diabetic complications and comorbid diseases (i.e., retinopathy, neuropathy, diabetic foot, hypertension, dyslipidemia), worsened glycemic levels, increased carbohydrate consumption, and snacking were associated with higher anxiety and depression scores. Depression was higher in patients with T2D and duration of illness was correlated with acute stress level. Conclusions: It is important to be aware of the possibility of acute stress, depression, and anxiety after pandemic in patients with DM whose glycemic control is impaired. Psychological problems should not be ignored beyond physical inactivity and worsening eating habits. [ABSTRACT FROM AUTHOR]